IQVIA Holdings Inc. (IQV)
NYSE·Healthcare·Medical - Diagnostics & Research
$159.19
-2.84%
Mkt Cap $30.00B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $4.24B | $4.36B | +2.93% | $3.40 | $3.42 | +0.59% | — | — |
| Q4 2025 Oct 28, 2025 | $4.08B | $4.10B | +0.50% | $2.98 | $3.00 | +0.67% | — | — |
| Q3 2025 Jul 22, 2025 | $3.97B | $4.02B | +1.19% | $2.77 | $2.81 | +1.44% | — | — |
| Q2 2025 May 6, 2025 | $3.77B | $3.83B | +1.49% | $2.63 | $2.70 | +2.66% | — | — |
| Q1 2025 Feb 6, 2025 | $3.93B | $3.96B | +0.78% | $3.11 | $3.12 | +0.32% | — | — |
| Q4 2024 Oct 31, 2024 | $3.87B | $3.90B | +0.79% | $2.82 | $2.84 | +0.71% | — | — |
| Q3 2024 Jul 22, 2024 | $3.79B | $3.81B | +0.65% | $2.56 | $2.64 | +3.13% | — | — |
| Q2 2024 May 2, 2024 | $3.70B | $3.74B | +0.96% | $2.49 | $2.54 | +2.01% | — | — |
| Q1 2024 Feb 14, 2024 | $3.80B | $3.91B | +2.99% | $2.82 | $2.84 | +0.71% | — | — |
| Q4 2023 Nov 1, 2023 | $3.78B | $3.74B | -1.04% | $2.46 | $2.49 | +1.22% | — | — |
| Q3 2023 Aug 1, 2023 | $3.71B | $3.73B | +0.52% | $2.37 | $2.43 | +2.53% | — | — |
| Q2 2023 Apr 27, 2023 | $3.61B | $3.65B | +1.05% | $2.41 | $2.45 | +1.66% | — | — |
| Q1 2023 Feb 10, 2023 | $3.71B | $3.74B | +0.85% | $2.75 | $2.78 | +1.09% | — | — |
| Q4 2022 Oct 26, 2022 | $3.54B | $3.56B | +0.61% | $2.39 | $2.48 | +3.77% | — | — |
| Q3 2022 Jul 21, 2022 | $3.49B | $3.54B | +1.34% | $2.39 | $2.44 | +2.09% | — | — |
| Q2 2022 Apr 27, 2022 | $3.54B | $3.57B | +0.83% | $2.43 | $2.47 | +1.65% | — | — |
| Q1 2022 Feb 15, 2022 | $3.59B | $3.64B | +1.23% | $2.43 | $2.55 | +4.94% | — | — |
| Q4 2021 Oct 21, 2021 | $3.35B | $3.39B | +1.22% | $2.13 | $2.17 | +1.88% | — | — |
| Q3 2021 Jul 27, 2021 | $3.35B | $3.44B | +2.62% | $2.07 | $2.13 | +2.90% | — | — |
| Q2 2021 Apr 22, 2021 | $3.17B | $3.41B | +7.60% | $1.85 | $2.18 | +17.84% | — | — |